Loading organizations...
Loading organizations...
High-quality recombinant protein and antibody reagents provider.
Biointron has raised $72.5M across 1 funding round.
Biointron has raised $72.5M in total across 1 funding round.
Biointron has raised $72.5M in total across 1 funding round.
Biointron's investors include CS Capital, Gaorong Capital, October Capital.
Biointron has raised $72.5M across 1 funding round. Most recently, it raised $72.5M Series B in August 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Aug 31, 2022 | $72.5M Series B | CS Capital, Gaorong Capital, October Capital |